Cancer drug resistance in multiple myeloma
Cancer Drug Resist
.
2022 Mar 25;5(2):271-276.
doi: 10.20517/cdr.2022.32.
eCollection 2022.
Author
Fatih M Uckun
1
2
Affiliations
1
Departmens of Oncology and Developmental Therapeutics, Ares Pharmaceuticals, St. Paul, MN 55110, USA.
2
Departmens of Translational Oncology, Reven Pharmaceuticals, Westminster, CO 80234, USA.
PMID:
35800374
PMCID:
PMC9255243
DOI:
10.20517/cdr.2022.32
No abstract available
Publication types
Editorial